Detalhe da pesquisa
1.
Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.
Infect Immun
; 92(3): e0045523, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289122
2.
A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.
Antimicrob Agents Chemother
; 60(12): 7206-7215, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27671061
3.
A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
PLoS One
; 19(5): e0294998, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713688
4.
A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague.
Microbiology (Reading)
; 158(Pt 6): 1593-1606, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22403187
5.
Predatory bacteria can protect SKH-1 mice from a lethal plague challenge.
Sci Rep
; 9(1): 7225, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076594
6.
Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.
PLoS One
; 13(10): e0200213, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296254
7.
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.
Genet Vaccines Ther
; 3(1): 3, 2005 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15842732
8.
Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice.
Peptides
; 43: 96-101, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23500517
9.
An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.
Vaccine
; 28(41): 6740-8, 2010 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20691267
10.
Small protective fragments of the Yersinia pestis V antigen.
Vaccine
; 27(21): 2775-80, 2009 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19366573
11.
Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.
Vaccine
; 25(2): 346-55, 2007 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-17007969
12.
Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
Infect Immun
; 75(11): 5425-33, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17646360
13.
A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection.
Infect Immun
; 70(3): 1653-6, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11854261
14.
Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.
Infect Immun
; 70(4): 2022-8, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11895967
15.
Enhancement of Insulin-Like Growth Factor I Activity by Novel Antisera: Potential Structure/Function Interactions1.
Endocrinology
; 141(2): 741-751, 2000 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28200821